SARS-CoV-2 Antigen Rapid Test Kit 5tests Packing

SARS-CoV-2 Antigen Rapid Test Kit 5tests Packing

Product Description

IMMUNOBIO SARS-CoV-2 Antigen Rapid Test Kit (colloidal gold method) is a solid-phase immunochromatography kit for rapid and qualitative detection of human nasopharyngeal swabs/nasal cavity/saliva swab specimens. This test only provides preliminary test results. Therefore, any reactive specimens using the test kit (colloidal gold method) must be confirmed by alternative test methods and clinical results.

This rapid test kit is the second set of test kits based on colloidal gold method developed by Singclean Medical since the antibody test kit Singclean IgG/IgM test kit was launched globally in March 2020.

Features

• Fast results in 10-15 minutes
•Help patients make treatment decisions quickly
•Simple and time-saving procedures
•Small sample, only a few swabs from the nose or throat
•Provide all necessary reagents, no equipment is required
• High sensitivity and specificity

Certificates

1.CE/ISO13485

2. Bfarm listed for professional and self Test kits

3. PEI

4. Registered in Germany/Italy/Austra/Poland/Argentina/Malaysia/Indonesia and etc.

Colloidal gold immunochromatography

It is a new type of immunolabeling technology that uses colloidal gold as a tracer and is applied to the detection of antigen and antibody. Chloroauric acid (HAuCl4) can polymerize into gold particles of a certain size under the action of a reducing agent to form a negatively charged hydrophobic gel solution. It becomes a stable colloidal state due to static electricity, so it is called colloidal gold. The colloidal gold test paper is to fix the biological macromolecules marked by colloidal gold on the test paper made of PVC material, leave the sample hole, and set up the detection line and the quality control line. After adding the sample to the sample hole, add the liquid medium dropwise, and perform chromatography on the test paper. According to the result of the immune reaction on the test paper, that is, whether there is a red band at the position of the colloidal gold, the test result is judged.

Packing detailes for Covid 19 ag Antigen Rapid Test kits we supply 

Product	Packing Information	Image
COVD -19 Rapid Antigen test	20 test kits packing Content: 1) 20 Foil pouches with test cassettes and desiccants 2) 20 tubes filled with buffer and dropper dippers 3) 20 Sterile swab 4) 20 droppers 6)1 Instruction for use 7) 1 tube holder Collection bag optioanal
COVD -19 Rapid Antigen test	5 test kits packing Content: 1) 5 Foil pouches with test cassettes and desiccants 2) 5 tubes filled with buffer and dropper dippers 3) 5 Sterile swab 4) 5 droppers 5)1 Instruction for use Collection bag optioanal
COVD-19 Rapid Antigen test	1 test kits packing Content: 1) 1 Foil pouches with test cassettes and desiccants 2) 1 tubes filled with buffer and dropper dippers 3) 1 Sterile swab 4) 1 droppers 5)1 Instruction for use Collection bag optioanal

Test producer for Antigen Saliva rapid test kit

Interpreted results
-Positive (+): Two colored lines appear. A colored line should always appear in the control line area (C), and the other line should appear in the T area.
*Note: The color intensity of the detection line area may vary with the concentration of SARS-CoV-2 in the specimen. Therefore, any shade of color in the test line area should be considered positive and recorded.
-Negative (-): A colored line appears in the control line area (C), and the T area is wireless.
—Invalid: The control line does not appear. Insufficient sample volume or incorrect programming technique is the most likely cause of control line failure. Review the process and repeat the test with a new test. If the problem persists, stop using the test kit immediately and contact your local dealer.

Limitation

1. SARS-CoV-2 antigen rapid test (COVID-19 Ag) is only used for in vitro diagnosis. This test is used to detect SARS-CoV-2 antigen in human throat and nasal secretions. In the case of saliva specimens, the viral load is usually low. If it is found to be negative in saliva but has symptoms of COVID-19, it is recommended to repeat the test with a throat swab or nasal swab. 2. The rapid SARS-CoV-2 antigen test (COVID-19 Ag) only indicates the presence of SARS-CoV-2 in the specimen and should not be used as the only criterion for the diagnosis of SARS-CoV-2 infection. 3 shown. If the symptoms persist and the rapid COVID-19 test result is negative or no response, it is recommended to delay re-sampling or PCR testing for a few days. 4 shown. As with all diagnostic tests, all results must be interpreted together with other clinical information available to the doctor. 5. If the test result is negative and the clinical symptoms persist, it is recommended to use other clinical methods for additional testing. At any time, a negative result cannot rule out the possibility of contracting COVID-19. 6. The potential impact of vaccines, antiviral therapies, antibiotics, chemotherapy or immunosuppressive drugs has not been evaluated in trials. 7 shown. Due to the inherent differences between methods, it is strongly recommended to conduct method correlation studies to determine technical differences before switching from one technology to another. Due to the difference in technology, you should not expect the results to be 100% consistent. 8. Performance is only determined based on the sample types listed in the intended use. Other specimen types have not been evaluated and should not be used in this test.